natgillin/translations-raw huggingface dataset:
Immediate discontinuation of therapy, careful observation, and initiation of appropriate supportive measures (blood transfusions, dialysis, haemofiltration, anti-infectious therapy, etc.) are the indicated treatment of overdose of cladribine.
Indicirano zdravljenje za preveliko odmerjanje kladribina so takojšnja prekinitev zdravljenja, skrbno opazovanje in uvedba ustreznih podpornih ukrepov (transfuzije krvi, dializa, hemofiltracija, zdravljenje proti okužbi, itd.).
Immediate hypersensitivity reactions have been reported after administration of indacaterol or glycopyrronium, which are components of Ultibro Breezhaler.
Poročali so o primerih takojšnje preobčutljivostne reakcije po odmerjanju indakaterola oziroma glikopironija, ki sta učinkovini zdravila Ultibro Breezhaler.
Immediate hypersensitivity reactions have been reported after administration of indacaterol or glycopyrronium, which are components of Ulunar Breezhaler.
Poročali so o primerih takojšnje preobčutljivostne reakcije po odmerjanju indakaterola oziroma glikopironija, ki sta učinkovini zdravila Ulunar Breezhaler.
Immediate hypersensitivity reactions have been reported after administration of indacaterol or glycopyrronium, which are components of Xoterna Breezhaler.
Poročali so o primerih takojšnje preobčutljivostne reakcije po odmerjanju indakaterola oziroma glikopironija, ki sta učinkovini zdravila Xoterna Breezhaler.
immediate hypersensitivity reactions including flushing, erythema, dyspnoea
takojšnje preobčutljivostne reakcije, vključno z zardevanjem, eritemom, dispnejo
immediate injection site pain, stinging and burning feeling
takojšnja bolečina na mestu vboda, občutek zbadanja in pekoč občutek,
Immediate injection site pain, stinging and burning sensation
takojšnja bolečina na mestu vboda, občutek zbadanja in pekoč občutek
immediate loss of vision or
takojšnja izguba vida ali
immediate loss of vision or;
takojšnja izguba vida ali
Immediate mild hypersensitivity-like reactions may occur commonly after vaccination, resulting in transient clinical signs such as vomiting.
Takoj po cepljenju se lahko pojavijo blage reakcije, podobne preobčutljivostnim reakcijam, ki se kažejo s prehodnimi kliničnimi znaki kot je bruhanje.
Immediate mild hypersensitivity-like reactions may occur commonly after vaccination, resulting in transient clinical signs such as vomiting.
Takoj po cepljenju se lahko pojavijo blage reakcije, podobne preobčutljivostnim reakcijam, ki sekažejo s prehodnimi kliničnimi znaki kot je bruhanje.
IMMEDIATE OUTER CARTON FOR FUZEON VIALS
PRIMARNA ZUNANJA OVOJNINA ZA VIALE FUZEON
IMMEDIATE OUTER CARTON FOR WATER FOR INJECTIONS VIALS
PRIMARNA ZUNANJA OVOJNINA ZA VIALE Z VODO ZA INJEKCIJE
Immediate Packaging
dovoljenja za
Immediate Packaging
EU/01/13/878/001
Immediate Packaging
EU/1/04/298/002
Immediate Packaging
EU/1/13/891/021
Immediate Packaging
EU/1/14/953/001
Immediate Packaging
nastavkom
Immediate Packaging
Odmerek
Immediate Packaging
Ovojnina
Immediate packaging
Stičnih Ovojninah
Immediate Packaging
uporabe
Immediate Packaging
Vsebina
Immediate packaging (blister foil)
Primarna ovojnina (pretisni omot)
Immediate packaging (blister foil)
Stična ovojnina (folija pretisnega omota)
Immediate packaging (blister foil)
Vnútorný obal (pretlačovacie balenie)
Immediate Packaging blister
pretisni omot
Immediate packaging HDPE Bottle – 4 mg
Primarna ovojnina plastenka iz HDPE – 4 mg
Immediate Packaging HDPE Bottle – 8 mg
Primarna ovojnina plastenka iz HDPE – 8 mg
Immediate Packaging Powder: vial (glass) Solvent: vial (glass)
Prašek: viala (steklo) Vehikel: viala (steklo)
IMMEDIATE PACKAGING – TRIFOLD – 2-day treatment pack
PRIMARNA OVOJNINA – pakiranje za 2-dnevno zdravljenje
IMMEDIATE PACKAGING – TRIFOLD – 3-day treatment pack
PRIMARNA OVOJNINA – pakiranje za 3-dnevno zdravljenje
Immediate packaging: bottle label
Primarna ovojnina: nalepka na plastenki
Immediate post infusion plasma concentration* (g/dl)
Koncentracija v plazmi takoj po infuziji* (g/dl)
immediate reactions occurring after oral administration of the medicinal product before anaesthesia (= active substance-specific side effects) combined effects of 5-ALA, anaesthesia, and tumour resection (= procedure-specific side effects).
takojšnje reakcije, ki se pojavijo po peroralni uporabi zdravila, pred anestezijo (= neželeni učinki, značilni za zdravilno učinkovino); kombinirani učinki 5-ALA, anestezije in resekcije tumorja (= neželeni učinki, značilni za postopek).
Immediate systemic hypersensitivity- like reactions may occur after vaccination, resulting in minor neurological symptoms such as tremors and/or excitation, which normally resolve within minutes without requiring treatment.
Po cepljenju se lahko pojavijo takojšnje sistemske, preobčutljivostnim podobne reakcije z blagimi nevrološkimi simptomi v obliki tremorja in/ali razdraženosti, ki običajno minejo v nekaj minutah brez zdravljenja.
Immediate systemic hypersensitivity-like reactions may occur after vaccination, resulting in minor neurological symptoms such as tremors and/or excitation, which normally resolve within minutes without requiring treatment.
Po cepljenju se lahko pojavijo takojšnje sistemske, preobčutljivostnim podobne reakcije z blagimi simptomi v obliki tremorja ali razdraženosti, ki običajno minejo v nekaj minutah brez zdravljenja.
Immediate-release cysteamine bitartrate
Cisteaminijev bitartrat s takojšnjim sproščanjem
Immediate-release exenatide 10 mcg BID
eksenatid v obliki s takojšnjim sproščanjem 10 μg dvakrat na dan
Immediate-release exenatide 5 mcg BID
eksenatid v obliki s takojšnjim sproščanjem 5 μg dvakrat na dan
Immediate-release exenatide and basal insulin must be administered as two separate injections.
Eksenatid v obliki s takojšnjim sproščanjem in bazalni insulin je potrebno dati v dveh ločenih injekcijah.
Immediate-release guanfacine tablets should not be substituted on a mg/mg basis, because of differing pharmacokinetic profiles.
Tablet gvanfacina s takojšnjim sproščanjem ne smemo zamenjati s tabletami s podaljšanim sproščanjem na podlagi mg/mg zaradi različnih farmakokinetičnih profilov.
Immediately after application, wipe the finger(s) you have used to apply the gel and any healthy skin touched by the gel with a disposable tissue.
Takoj po uporabi si s krpicoza enkratno uporabo obrišite prst(e), ki ste ga (jih) uporabili za nanos gela, kot tudi vse dele zdrave kože, ki so prišli v stik z gelom.
Immediately after injecting OZURDEX, use indirect ophthalmoscopy in the quadrant of injection to confirm successful implantation.
Takoj po injiciranju zdravila OZURDEX uporabite indirektno oftalmoskopijo v kvadrantu injiciranja, da potrdite uspešno vstavljanje vsadka.
Immediately after OPTISON injection, the intravenous infusion should be wide open until contrast begins to fade from the left ventricle.
Takoj po injiciranju kontrastnega sredstva OPTISON je treba široko odpreti pretok intravenske infuzije, dokler ne začne kontrast v levem ventriklu izginjati.
Immediately after release in the patient’s circulation, Factor VIII binds to von Willebrand factor (vWF).
Faktor VIII se nemudoma po vstopu krvni obtok veže na von Willebrandov faktor (vWF).
Immediately after the injection into your vein, you will also be given this medicine as an injection under your skin (subcutaneous injection).
Takoj po injiciranju v veno vam bo to zdravilo vbrizgano tudi pod kožo (subkutano injiciranje).
Immediately after use – take the dispenser to pieces and rinse it under running tap water.
Takoj po uporabi – razdelilnik razstavite in ga sperite pod tekočo vodo.
Immediately after you self-inject Firazyr or your caregiver injects you with Firazyr while you are experiencing a laryngeal attack (obstruction of the upper airway), you must seek medical care in a medical institution.
Če si zdravilo Firazyr injicirate med laringealnim napadom (neprehodnost zgornjih dihal) ali vam ga injicira negovalec, se morate takoj po tem obrniti na zdravniško pomoč v zdravstveni ustanovi.
Immediately and permanently discontinue treatment with necitumumab. a Grade per NCI-CTCAE, Version 3.0
Takoj in trajno prekinite zdravljenje z necitumumabom. a Stopnja po NCI-CTCAE (Merila pogostih toksičnosti Nacionalnega inštituta za rakava obolenja), različica 3.0.
Immediately and permanently discontinue treatment with necitumumab. a Grade per NCI-CTCAE, Version 3.0 b Once the infusion rate has been reduced for a Grade 1 or 2 hypersensitivity/infusion-related reaction, it is recommended that the lower infusion rate be utilized for all subsequent infusions.
Takoj in trajno prekinite zdravljenje z necitumumabom. a Stopnja po NCI-CTCAE (Merila pogostih toksičnosti Nacionalnega inštituta za rakava obolenja), različica 3.0. b Če hitrost infundiranja zmanjšate zaradi preobčutljivostne reakcije/reakcije, povezane z infuzijo stopnje 1 ali 2, je priporočljivo, da zmanjšano hitrost infundiranja uporabljate pri vseh nadaljnjih infuzijah.
Immediately and permanently discontinue treatment with olaratumab (see section 4.4). a Grade per National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), Version 4.03 b Once the infusion rate has been reduced for a Grade 1 or 2 infusion-related reaction, it is recommended that the lower infusion rate be utilized for all subsequent infusions.
Zdravljenje z olaratumabom takoj in trajno ukinite (glejte poglavje 4.4). a Stopnja, opredeljena po Skupnih terminoloških merilih za opredeljevanje neželenih dogodkov Nacionalnega onkološkega inštituta (NCI CTCAE, National Cancer Institute Common Terminology Criteria for Adverse Events), različica 4.03 b Po zmanjšanju hitrosti infuzije zaradi reakcije, povezane z infuzijo, stopnje 1 ali 2 se pri vseh nadaljnjih infuzijah priporoča uporaba manjše hitrosti infuzije.
Immediately before administration, the solution should be inspected: the solution should be clear and must be free of lumps.
Neposredno pred dajanjem je treba pregledati videz raztopine: raztopina mora biti bistra in brez grudic.
Immediately before injection a careful visual inspection of the syringe is mandatory in order to ensure complete resuspension of the microspheres.
Tik pred injiciranjem morate obvezno natančno vizualno pregledati brizgo, da se prepričate o popolni resuspendiranosti mikrosfer.
Immediately before injection a careful visual inspection of the syringe is mandatory in order to ensure complete suspension of the microspheres.
Tik pred injiciranjem morate obvezno natančno vizualno pregledati brizgo, da se prepričate o popolni resuspendiranosti mikrosfer.
Immediately before use, with dry hands, remove one capsule from the blister.
Tik pred uporabo vzemite s suhimi rokami iz pretisnega omota eno kapsulo.
Immediately before using a bottle for the first time, tear open the overwrap pouch, take the bottle out (picture 1) and write the date of opening on the carton in the space provided
Tik pred prvo uporabo kapalnega vsebnika odprite omot, vzemite kapalni vsebnik iz njega (slika 1) in v prostor na škatli zapišite datum odpiranja.
Immediately before using a bottle for the first time, tear open the overwrap pouch, take the bottle out (picture 1) and write the date of opening on the carton in the space provided
Tik pred prvo uporabo raztrgajte omot, vzemite kapalni vsebnik iz njega (slika 1) in v prostor na škatli vpišite datum odprtja.
Immediately before using a bottle for the first time, tear-off the overwrap pouch take it out (picture 1) and write the date of opening on the label in the space provided.
Tik pred prvo uporabo raztrgajte omot, vzemite kapalni vsebnik iz njega (slika 1) in v prostor na nalepki kapalnega vsebnika vpišite datum odprtja.
Immediately connect the plunger rod to the syringe by turning it clockwise into
Takoj privijte nosilec bata v brizgo tako, da ga vrtite v smeri urinega kazalca v bat, ki je v napolnjeni injekcijski brizgi, dokler
Immediately connect the plunger rod to the syringe by turning it clockwise into the plunger inside the pre-filled syringe until resistance is felt.
Takoj privijte nosilec bata v injekcijsko brizgo, tako da ga vrtite v smeri urinega kazalca v bat, ki je v notranjosti napolnjene injekcijske brizge, dokler ne začutite upora.
Immediately contact the doctor or seek emergency treatment if they display any unusual behavioural symptoms, feel depressed, or feel they want to harm themselves or others.
Takoj obiščite zdravnika ali poiščite nujno medicinsko pomoč, če otrok kaže neobičajne simptome obnašanja, se počuti depresiven ali če želi škodovati sebi ali drugim.
Immediately contact the doctor or seek emergency treatment if they display any unusual behavioural symptoms, feel depressed, or feel they want to harm themselves or others.
Takoj poiščite nujno medicinsko pomoč, če otrok kaže neobičajne simptome obnašanja, se počuti depresiven ali če otrok želi škodovati sebi ali drugim.
Immediately discard syringe with covered needle into a sharps container.
Brizgo s pokrito iglo takoj zavrzite v vsebnik za ostre odpadke.
Immediately discard used Nplate vial into an appropriate waste container.
Uporabljeno vialo zdravila Nplate takoj zavrzite v ustrezen vsebnik za odpadke.
Immediately discontinue dinutuximab and intravenous GM-CSF or IL- 2.
Takoj prekinite z dinutuksimabom in intravenskim dajanjem GM-CSF ali IL-2.
Immediately give them milk, formula or breast-milk to drink to ensure the granules are completely swallowed and none remain in your child’s mouth.
Takoj mu dajte mleko, formulo ali materino mleko, da bo zrnca popolnoma pogoltnil in del odmerka ne bo ostal v otrokovih ustih.
Immediately inject the solution as follows: Firmly pinch the skin together and insert the needle at a 45° to 90° angle using a dart-like motion.
Takoj injicirajte raztopino, kot je opisano: trdno stisnite kožo skupaj in z gibom podobnim metu sulice, zabodite iglo pod kotom 45° do 90°.
Immediately inject the solution.
Takoj injicirajte raztopino.
Immediately inject the solution: Your doctor or nurse will have already advised you where to inject (e.g. tummy, front of thigh).
Takoj injicirajte raztopino: zdravnik ali medicinska sestra sta vam že svetovala, kam dati injekcijo (npr. v trebuh, sprednjo stran stegna).
Immediately inject the solution: Your doctor or nurse will have already advised you where to inject (e.g. tummy, front of thigh).
Takoj si vbrizgajte raztopino: Vaš zdravnik ali sestra sta vas že poučila kje dati injekcijo (npr. v
Immediately inject the solution: Your doctor or nurse will have already advised you where to inject (e.g. tummy, front of thigh).
Takoj vbrizgajte raztopino: Vaš zdravnik ali sestra sta vas že poučila, kje dati injekcijo (npr. v
Immediately invert the vial of solution, which will be drawn into the syringe.
Takoj obrnite vialo z raztopino, ki jo bo potegnilo v injekcijsko brizgo.
Immediately place the used syringe in a sharps disposal container.
Uporabljeno brizgo nemudoma dajte v vsebnik za ostre odpadke.
Immediately preceding or simultaneous treatment with vincristine can increase the toxicity of Oncaspar and increases the risk of anaphylactic reactions.
Uporaba vinkristina neposredno pred ali sočasno z zdravilom Oncaspar lahko poveča toksičnost zdravila Oncaspar in poveča tveganje za anafilaktične reakcije.
Immediately prepare new syringe for injection
Takoj pripravite novo brizgo za injiciranje.
Immediately prior to use, contents of the vial are reconstituted in the unlabeled form to prepare LeukoScan [99mTc].
Za pripravo zdravila LeukoScan 99mTc je potrebno z radioizotopom neoznačeno vsebino viale neposredno pred uporabo rekonstituirati.
Immediately replace the cap.
Takoj namestite zaporko.
Immediately swallow the solution direct from the
Raztopino takoj zaužijte neposredno iz brizge.
Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage.
Nemudoma zaužijte približno 10 do 20 gramov sladkorja glukozo, kocke sladkorja ali s sladkorjem sladkane pijače.
Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage.
Nemudoma zaužijte približno 10 do 20 gramov sladkorja v obliki glukoze, kock sladkorja ali s sladkorjem sladkane pijače.
Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage.
Nemudoma zaužijte približno 10 do 20 gramov sladkorja, v obliki glukoze, kock sladkorja ali s sladkorjem sladkane pijače. (Enkrat z žlico, kockami sladkorja ali tabletami glukoze ugotovite, kolikšna količina je to).
Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage.
Nemudoma zaužijte približno 10 do 20 gramov sladkorjav obliki glukoze, kock sladkorja ali s sladkorjem sladkane pijače.
Immediately thereafter, open the bottle by removing the child resistant screw cap.
Takoj potem odprite steklenico tako, da odstranite za otroke varno navojno zaporko.
Immediately thereafter, the bottle should be opened by removing the child-resistant screw cap.
Takoj potem je treba steklenico odpreti tako, da se odstrani za otroke varna navojna zaporka.
Immediately throw away the needle cap in the sharps/ puncture-resistant container or sharps container.
Pokrov ek igle nemudoma zavrzite v vsebnik za odpadni material, ki je odporen proti vbodom.
Immediate–release tablets release the active substance immediately, and prolonged-release tablets release it slowly over a few hours.
Iz tablet s takojšnjim sproščanjem se zdravilna učinkovina sprosti takoj, iz tablet s podaljšanim sproščanjem pa se sprošča več ur.
Immedicate Packaging
ovojnina
Immune cells are excreted in human milk in low amounts.
Imunske celice se v materino mleko izločajo v majhnih količinah.
immune disorders such as sarcoidosis (rash, joint pain, fever), serum sickness, inflammation of the fat tissue, angioneurotic oedema (swelling of the lips, face, throat)
obolenja imunskega sistema, kot so sarkoidoza (izpuščaj, bolečine v sklepih, zvišana telesna temperatura), serumska bolezen, vnetje maščobnega tkiva, angionevrotski edem (otekanje ustnic, obraza in grla)
immune disorders that could affect the lungs, skin and lymph nodes ( most commonly presenting as sarcoidosis);
imunske bolezni, ki lahko prizadanejo pljuča, kožo ali limfne vozle (najpogosteje kot pojav sarkoidoze);
immune disorders that could affect the lungs, skin and lymph nodes (most commonly presenting as sarcoidosis)
melanom; imunske bolezni, ki lahko prizadanejo pljuča, kožo in limfne vozle (najpogosteje kot sarkoidoza)
Immune disorders that could affect the lungs, skin and lymph nodes (most commonly presenting as sarcoidosis)
motnje imunskega sistema, ki lahko vplivajo na pljuča, kožo in bezgavke (najpogosteje se kaže kot sarkoidoza),
immune disorders that could affect the lungs, skin and lymph nodes (most commonly presenting as sarcoidosis);
imunske bolezni, ki lahko prizadanejo pljuča, kožo ali limfne vozle (najpogosteje kot sarkoidoze);
immune disorders that could affect the lungs, skin and lymph nodes (most commonly presenting as sarcoidosis);
imunske bolezni, ki lahko prizadanejo pljuča, kožo in limfne vozle (najpogosteje kot sarkoidoze);
immune disorders that could affect the lungs, skin and lymph nodes (most commonly presenting as sarcoidosis);
melanom; imunske bolezni, ki lahko prizadanejo pljuča, kožo in limfne vozle (najpogosteje kot sarkoidoza);
Immune disorders that could affect the lungs, skin and lymph nodes (such as sarcoidosis)
imunske bolezni, ki lahko prizadenejo pljuča, kožo in bezgavke (na primer sarkoidoza)
Immune disorders that could affect the lungs, skin and lymph nodes (such as sarcoidosis)
imunske bolezni, ki lahko prizadenejo pljuča, kožo in bezgavke (na primer sarkoidoza),
Immune disorders that could affect the lungs, skin and lymph nodes (such as sarcoidosis).
imunske bolezni, ki lahko prizadenejo pljuča, kožo in bezgavke (na primer sarkoidoza)
Immune globulin
Imunoglobulini
Immune globulin (IG) is not to be given concomitantly with M-M-RVAXPRO.
Sočasno s cepivom M-M-RVAXPRO ne dajajte imunoglobulinov (IG).
Immune glogulin
Imunoglobulini
Immune mediated haemolytic anaemia (antibody-mediated destruction of red blood cells)
Hemolitična anemija (anemija zaradi propada rdečih krvnih celic)
Immune mediated haemolytic anaemia (antibody-mediated destruction of red blood cells)
imunsko pogojena hemolitična anemija (propad rdečih krvnih celic, ki ga povzročijo protitelesa)
Immune mediated haemolytic anaemia*
Imunsko posredovana hemolitična anemija
immune reactivation syndrome
sindrom obnove imunskega odgovora
immune reactivation syndrome1
sindrom imunske reaktivacije1
Immune Reactivation Syndrome: In HIV-infected patients with severe immune deficiency at the time of institution of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic pathogens may arise and cause serious clinical conditions, or aggravation of symptoms.
Sindrom imunske reaktivacije: pri s HIV okuženih bolnikih s hudo imunsko pomanjkljivostjo lahko ob uvedbi kombiniranega protiretrovirusnega zdravljenja (CART – ''combination antiretroviral therapy'') nastane vnetna reakcija na asimptomatične ali rezidualne oportunistične patogene in povzroči resna klinična stanja ali poslabšanje simptomov.
Immune reconstitution inflammatory syndrome
Sindrom obnove imunskega odgovora
immune reconstitution inflammatory syndrome, (drug) hypersensitivity
vnetni sindrom imunskega odgovora, preobčutljivost (na zdravilo)
immune reconstitution inflammatory syndrome, (drug) hypersensitivity
vnetni sindrom obnove imunskega odgovora, preobčutljivost (na zdravilo)
Immune Reconstitution InflammatorySyndrome
Vnetni sindrom imunske rekonstitucije
Immune reconstitution syndrome
Vnetni sindrom imunske obnove
immune reconstitution syndrome (0.2% vs 0.3%), drug hypersensitivity (0.8% vs 1.2%)
sindrom imunske obnove (0,2% v primerjavi z 0,3%), preobčutljivost za zdravila (0,8% v primerjavi z 1,2%)
Immune Reconstitution Syndrome (see section 4.4)**
sindrom imunske rekonstitucije (glejte poglavje 4.4)
immune reconstitution syndrome (see section 4.4)2
sindrom imunske rekonstitucije (glejte poglavje 4.4)2
Immune reconstitution syndrome happens when the patient’s immune system starts working again and fights existing infections, causing inflammation at the site of the infection.
Do sindroma imunske obnove pride, ko prične bolnikov imunski sistem ponovno delovati ter se boriti proti obstoječim okužbam, kar povzroči vnetje na mestu okužbe.
Immune reconstitution syndrome happens when the patient’s immune system starts working again and fights existing infections, causing inflammation at the site of the infection.
Sindrom imunske reaktivacije nastopi, ko začne bolnikov imunski sistem ponovno delovati in se boriti proti obstoječim okužbam, kar povzroči vnetje na okuženem mestu.
immune reconstitution syndrome, drug hypersensitivity, hypersensitivity
sindrom imunske obnove, preobčutljivost na zdravilo, preobčutljivost
Immune related findings of minimal, nonprogressive, lymphoid hyperplasia in spleen, lymph nodes and bone marrow with no adverse sequelae have been reported in all species tested at exposures starting from 7 times the RHD.
Pri vseh testiranih živalskih vrstah so ob izpostavljenostih, ki so se začele s 7-krat tolikšno izpostavljenostjo kot je dosežena s priporočenim odmerkom za človeka, opazili imunske spremembe: minimalno, neprogresivno limfatično hiperplazijo v vranici, bezgavkah in kostnem mozgu, brez neželenih posledic.
Immune response against a version of Celvapan containing A/H5N1 vaccine strains
Odziv imunskega sistema na različico cepiva Celvapan, ki vsebuje sev A/H5N1
Immune response against A/Indonesia/5/2005 (H5N1)
Imunski odziv proti A/Indonesia/5/2005 (H5N1):
Immune response against A/Vietnam/1203/2004 (H5N1)
Imunski odziv na A/Vietnam/1203/2004 (H5N1)
Immune response against A/Vietnam/1203/2004 (H5N1)
Odziv imunskega sistema na sev A/Vietnam/1203/2004 (H5N1)
Immune response against the vaccine strain contained in PANDEMIC INFLUENZA VACCINE H5N1 BAXTER (A/Vietnam/1203/2004)
Odziv imunskega sistema na sev, ki je v cepivu PANDEMIC INFLUENZA VACCINE H5N1 BAXTER (A/Vietnam/1203/2004)
Immune response syndrome
Sindrom imunskega odziva/imunske reaktivacije
Immune response to A/California/7/2009 (H1N1)v-like
Imunski odziv proti A/California/7/2009 (H1N1)v- podobnemu sevu
Immune response to A/Indonesia/5/2005
Imunski odziv na A/Indonesia/5/2005